chartexchange

VB Spine Announces FDA Breakthrough Device Designation for New Blood Test Designed to Identify Patients at Risk for Scoliosis Progression

Business Wire | Sep 29, 2026 8:10 AM EDT

NEW YORK--(BUSINESS WIRE)--VB Spine has received FDA Breakthrough Device Designation for a new blood test designed to identify patients at risk for scoliosis progression.

Read original article